Urinary urgency and increased urinary frequency were significantly improved in the estrogen group after 6 months.Conclusion There was no evident benefit related to complications such as ulcerations, itching, and vaginal discharge/odor from the use of vaginal estrogen in POP women using pessaries....
therapies are effective for treating these symptoms. However, when urogenital atrophy is the main or only indication for estrogen, topical vaginal estrogen therapies (creams,pessaries, intravaginal tablets, andestradiolrings) are preferred due to low systemic absorption and reduced risk of adverse ...
Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2 mg and 0.03 mg estriol. Maturitas 71, 360–368 (2012). Article CAS PubMed Google Scholar Sánchez-Rovira, P., Hirschberg, A. ...
2. one or more contraindications for the use of hormonal contraception: smoking ≥20 cigarettes/day; acute venous thromboembolic disease or increased risk; known hereditary or acquired predisposition for venous thrombosis, e.g. activated protein
An alternative choice is oestrogenic preparations administered vaginally (in the form of creams, pessaries, tablets and the estradiol releasing ring). Objectives: The objective of this review is to compare the effectiveness, safety and acceptability of oestrogenic preparations for women who suffer from...
Over the years, several vaginal products including different formulations (tablets, rings, capsules, pessaries, creams, gels and ovules) and molecules (estradiol [E2], estriol [E3], promestriene, conjugated equine estrogens and estrone) have been used with superimposable therapeutic results. Low-...
Leeton J, Rogers P, Cameron I, Caro C, Healy D: Pregnancy results following embryo transfer in women receiving low- dosage variable-length estrogen replacement therapy for premature ovarian failure. J Vitro Fert Embryo Transfer 1989;6(4):232-235...